Eikon Therapeutics, Inc. (EIKN): 5 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Feb 9, 2026 | Column Group Opportunity III, LP TenPercentOwner | 2,117,760 | $18.00 | $38.1M | no history |
| Feb 6, 2026 | Lux Ventures V, L.P. TenPercentOwner | 277,776 | $18.00 | $5.0M | no history |
| Feb 6, 2026 | Wolfe Josh Director, TenPercentOwner | 277,776 | $18.00 | $5.0M | no history |
| Feb 6, 2026 | Frazier Kenneth C Director | 111,111 | $18.00 | $2.0M | no history |
| Feb 6, 2026 | Foresite Capital Opportunity Management V, LLC TenPercentOwner | 55,555 | $18.00 | $1000.0K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.